Innovation In Phase 1 Clinical Development June 25 - 27, 2012 Boston, MA

Date: May-01-2012Reducing Costs of Your Studies & Eliminating Errors for a Smooth Transition to Phase 2 Development

While several strategies, such as outsourcing and strategic partnerships, have been tried and tested, there has been no definitive answer to resolve the financial dilemma that exists within clinical trials.

Attend Innovation in Phase 1 Clinical Development to hear successful implementations of cost saving strategies. This phase 1 clinical trial event will help you transition to Phase 2 production faster and more cost effectively.

You will hear case studies from the top pharmaceutical and biotech companies including Pfizer, Merck, GlaxoSmithKline, Bristol Meyers Squibb, Takeda Global R&D, Abbott Laboratories and more. The presentations will teach you about:
New one platform technologies that have been proven to improve efficiency and decrease errors by effectively storing and maintaining data obtained during your research phase

Mitigating the impact of the User Fee Legislation and other FDA guidelines that will affect your organization

The necessary project management skills your employees need in order to improve on internal practices used to select the optimal population for phase 1 clinical trials

The importance of recruitment and retention of populations and long term sequestered studies

Biomarkers and working with pharmaceutical companies who have been averse to disclosing pertinent information

Strategies that will attract funding from new big Pharma venture capital arms for current and future research studies

Visit http://bit.ly/IQ7eyY to view the brochure or to register.
Courtesy: Medical News Today Note: Any medical information available in this news section is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional.